(Stroke. 1997;28:2219-2221.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Neurology, Tokyo Medical and Dental University (M.Y., N. Sodeyama, H.M.); Departments of Internal Medicine (Y.I., E.O.) and Pathology (N. Suematsu), Yokufukai Geriatric Hospital; and Department of Psychiatry, University of Tokyo (M.M.), Tokyo, Japan.
Correspondence to Dr Masahito Yamada, Department of Neurology, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113, Japan. E-mail m-yamada.nuro{at}med.tmd.ac.jp
Background and Purpose An intronic polymorphism of presenilin-1 (PS-1), a gene responsible for early-onset familial Alzheimer's disease, has been reported to be associated with late-onset sporadic Alzheimer's disease. In a search for a genetic risk factor of sporadic cerebral amyloid angiopathy (CAA), we investigated the association of the polymorphism of PS-1 with CAA.
Methods The association between the severity of CAA and genotypes of a polymorphism in intron 8 of PS-1 was investigated in 137 autopsy cases of the elderly.
Results A significant decrease of PS-1 2/2 genotype frequency was associated with severe or moderate CAA.
Conclusions Our results suggest that PS-1 intronic polymorphism may be associated with the severity of CAA in the elderly.
Key Words: Alzheimer's disease amyloid elderly polymorphism (genetics)
This article has been cited by other articles:
![]() |
P. Thomas and M. Fenech Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease Mutagenesis, January 1, 2008; 23(1): 57 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Hamaguchi, S Okino, N Sodeyama, Y Itoh, A Takahashi, E Otomo, M Matsushita, H Mizusawa, and M Yamada Association of a polymorphism of the transforming growth factor-{beta}1 gene with cerebral amyloid angiopathy J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 696 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Yamada, N Sodeyama, Y Itoh, A Takahashi, E Otomo, M Matsushita, and H Mizusawa Association of neprilysin polymorphism with cerebral amyloid angiopathy J. Neurol. Neurosurg. Psychiatry, June 1, 2003; 74(6): 749 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamada, N. Sodeyama, Y. Itoh, E. Otomo, M. Matsushita, and H. Mizusawa No Association of Paraoxonase Genotype or Atherosclerosis With Cerebral Amyloid Angiopathy Stroke, April 1, 2002; 33(4): 896 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamada, N. Sodeyama, Y. Itoh, N. Suematsu, E. Otomo, M. Matsushita, and H. Mizusawa A Deletion Polymorphism of {alpha}2-Macroglobulin Gene and Cerebral Amyloid Angiopathy Stroke, November 1, 1999; 30 (11): 2277 - 2279. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamada, N. Sodeyama, Y. Itoh, N. Suematsu, E. Otomo, M. Matsushita, and H. Mizusawa Butyrylcholinesterase K Variant and Cerebral Amyloid Angiopathy Stroke, December 1, 1998; 29(12): 2488 - 2490. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |